Comparison of Post Operative Analgesia following Epidural Bupivacaine with Clonidine and Epidural Bupivacaine in Orthopaedic Lower Limb Surgeries by Karthik, K
DISSERTATION ON COMPARISON OF POST 
OPERATIVE ANALGESIA FOLLOWING EPIDURAL 
BUPIVACAINE WITH CLONIDINE AND EPIDURAL 
BUPIVACAINE IN ORTHOPAEDIC LOWER 
LIMB SURGERIES 
Dissertation submitted to
TAMIL NADU DR. M.G.R. MEDICAL UNIVERSITY
Chennai
for 
MD (ANAESTHESIOLOGY) Branch - X
March 2009
GOVT. STANLEY MEDICAL COLLEGE
Chennai 
THE TAMIL NADU Dr. M.G.R. MEDICAL UNIVERSITY
CHENNAI – TAMIL NADU
1
CERTIFICATE
This  is  to  certify  that  this  dissertation  entitled  dissertation  on 
“COMPARISON  OF  POST  OPERATIVE  ANALGESIA  FOLLOWING 
EPIDURAL  BUPIVACAINE  WITH  CLONIDINE  AND  EPIDURAL 
BUPIVACAINE IN ORTHOPAEDIC LOWER LIMB SURGERIES”  is  the 
bonafide  original  work  of  Dr.K.KARTHIK,  in  partial  fulfillment  of  the 
requirement for MD anaesthesiology examination of the  Tamilnadu Dr. MGR 
Medical University to be held in March 2009. 
Prof. Dr. J. Mohanasundaram
                     M.D. Phd. D.N.B.
DEAN,
Govt. Stanley Medical College &
Hospital, 
Chennai-600 001.
Prof.Dr.P.Chandrasekar 
                         M.D. D.A., 
Head of the department
Department of Anaesthesiology,
Govt. Stanley Medical College & 
Hospital, Chennai-600 001.
2
DECLARATION
I,  Dr.K.KARTHIK,  solemnly  declare that dissertation titled, Dissertation 
on  “COMPARISON OF POST OPERATIVE ANALGESIA FOLLOWING 
EPIDURAL  BUPIVACAINE  WITH  CLONIDINE  AND  EPIDURAL 
BUPIVACAINE IN ORTHOPAEDIC LOWER LIMB SURGERIES” is  the 
bonafide work  done by me at Govt.Stanley medical college  and hospital during 
the  period  January  2008  to  August  2008  under  the  expert   guidance  and 
supervision of Prof. Dr. P. Chandrasekar M.D. D.A. 
The dissertation is submitted to the Tamilnadu Dr. MGR Medical university 
towards  partial  fulfillment  of  requirement  for  the  award  of   MD  Degree  in 
anaesthesiology.
Place : Chennai
3
Date :                                                            Dr. K. KARTHIK
                                                     ACKNOWLEDGEMENT
I  am extremely  thankful  to  PROF.DR.J.  MOHANASUNDARAM MD, 
Phd, DNB, Dean, Stanley Medical College, Chennai for permitting me to do this 
study in our Institution. 
I  take  this  opportunity  to  express  my  heartfelt  gratitude  to   PROF. 
DR. P. CHANDRASEKAR, MD,DA., Professor and head of the department  of 
anaesthesiology, Stanley Medical College, Chennai, for his keen interest, constant 
encouragement, guidance and valuable suggestions throughout this study.
I am extremely thankful to PROF. DR. B. KALA, M.D,D.A., Professor of 
Anesthesiology,Stanely Medical College,Chennai, who has extented her unstinted 
encouragement, guidance and valuable suggestiosS during the study. 
My sincere  thanks  to  PROF.  DR.  R.  MATHAN KUMAR, M.D, D.A., 
Professor  of  Anesthesiology,  Stanely  Medical  College,  Chennai,  for  the 
encouragement and guidance extended to me during the study. 
4
My Sincere thanks to  PROF.DR. S. GUNASEKAR, M.D, D.A., D.N.B, 
Professor  of  Anesthesiology,  Stanely  Medical  College,  Chennai,  for  the 
encouragement and guidance extended to me during the study. 
e
I  am  extremely  thankful  to  DR.  N.  BASKER,  M.D, Asst.  
Professor, Department of Anesthesiology, for his guidance.
          I thank ALL ASSISTANT PROFESSORS who evinced keen interest and 
gave support without which this study would not have been possible.
I thank Mr. PADMANABAN, Statistician, for helping me in the statistical 
analysis.
I thank all Post graduates for their valuable support during the study period.
I thank all theatre personnel for their co-operation.  
           I thank all patients without whose participation, this study would not have 
been possible. 
5
                                             CONTENTS
S.NO CONTENTS PAGE NO
1. INTRODUCTION 1
2. AIMS AND OBJECTIVES 4
3. PHYSIOLOGY OF PAIN 5
4. EFFECTS OF POSTOPERATIVE PAIN 7
5. ROLE OF EPIDURAL ANALGESIA 8
6. POSTOPERATIVE ANALGESIA IN 
ORTHOPAEDICS
9
7. BUPIVACAINE 10
8. CLONIDINE 14
9. REVIEW OF LITERATURE 18
10. MATERIALS AND METHODS 30
11. OBSERVATIONS 37
12. DISCUSSION 56
13. SUMMARY 59
14. CONCLUSION 61
ANNEXURES
BIBLIOGRAPHY
PROFORMA
MASTER CHART
6
6INTRODUCTION
           Recent advances in neurosciences have demonstrated that peripheral tissue 
injury may lead to long alterations in central processing with reduction in pain 
threshold,  amplification  of  response  to  pain.  Comparable  alterations  may  also 
occur  following surgical trauma, resulting in amplification and prolongation of 
postoperative pain. 
           Postoperative pain treatment should be an integral component of the routine 
surgical and anaesthetic management not only for humanitarian reasons  but also 
because it can help to reduce morbidity and complications as well as accelerate 
rehabilitation .Good perioperative analgesia is an important avenue to attenuate the 
surgical stress response 
      Post operative pain relief can be provided by pharmacological and non-
pharmacological methods. Non pharmacological methods include hypnosis, cold or 
heat,  relaxation  therapy,  splinting  of  wounds,  Transcutaneous  Electrical  Nerve 
Stimulation  and  pre-operative  explanation  and  education.  The  pharmacological 
methods  include  simple  analgesics,  Non-  steroidal  anti-  inflammatory  drugs, 
Opioids (oral, intramuscular, intravenous, Patient Controlled Analgesia, Epidural 
or intrathecal) and Local anaesthetic agents ( wound infiltration, nerve blockade, 
epidural, intrathecal). 
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7        Epidural anaesthesia is a central neuraxial block technique with many 
applications. Epidural anaesthesia can be used as sole anaesthetic for procedures 
involving the lower limbs, pelvis, perineum and lower abdomen . The advantage of 
epidural over spinal anaesthesia is the ability to maintain continuous anaesthesia 
after placement of an epidural catheter, thus making it suitable for procedures of 
long  duration.  This  feature  also  enables  the  use  of  this  technique  into  the 
postoperative period for analgesia, using lower concentrations of  local anaesthetic 
drugs or in combination with different agents.
              Clonidine an alpha – 2 agonist drug, which was introduced into clinical 
practice as an anti-hypertensive medication, can be used as an additive to local 
anaesthetics  in  nerve  blockade  and central  neuraxial  blockade.  Following local 
anaesthetics  and  opioids,  clonidine  is  the  most  studied  drug  used  for  human 
neuraxial analgesia. Although the systemic administration of clonidine can provide 
analgesia, its primary site of antinociceptive action appears to be at the spinal level. 
Alpha - 2 receptors at the spinal cord level are thought to be responsible for the 
analgesic properties of α2-adrenergic agonists ( 10,11 ).
This study was designed to evaluate the analgesic efficacy of bupivacaine and 
clonidine  mixture  given  through  lumbar  epidural  route  in  patients  undergoing 
elective orthopaedic lower limb surgeries ,comparing the quality of analgesia with 
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epidural  plain  bupivacaine  and  also  to  calculate  the  number  of  post-operative 
aanalgesic doses required.
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9AIMS AND OBJECTIVES
1. To  evaluate  the  analgesic  efficacy  of   bupivacaine  and  clonidine 
mixture  given  through  lumbar  epidural  route  for  postoperative 
analgesia  in  patients  undergoing  elective  orthopaedic  lower  limb 
surgeries,  by  calculating  the  number  of  doses  of  postoperative 
analgesics required.
2. To  compare  the  quality  and  duration  of  analgesia  of  epidural 
bupivacaine - clonidine mixture with epidural plain bupivacaine intra 
and post- operatively.
3. To evaluate the hemodynamic response of epidural clonidine intra and 
post-operatively.
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1                                      DEFINITION OF PAIN
           The International Association for the Study of Pain (IASP)  defines pain as 
“an  unpleasant  sensory  and  emotional  experience   associated  with  actual  or 
potential tissue damage or described in terms of such damage.”
                                      PHYSIOLOGY OF PAIN
        Nociception is conveyed from the periphery to the brain at three levels:the 
peripheral nociceptor, the spinal cord, and the supra-spinal (brain) levels(1).
There are two types of pain- Physiological and Pathological.
I  .  PHYSIOLOGICAL  PAIN  :is  produced  by  stimulation  of  high  threshold 
thermo/mechanical nociceptors, which transmit via fast conducting myelinated A 
delta fibres. These enter the dorsal horn of the spinal cord and synapse at laminae I 
and V. 
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II . PATHOLOGICAL PAIN: originates from stimulation of the high threshold 
polymodal  nociceptors  (free  endings)  present  in  all  tissues.  The  nociceptors 
respond to mechanical, chemical and thermal stimuli and are transmitted via slow 
conducting unmyelinated C fibres. These synapse at 
laminae  II  and III  (substantia  gelatinosa)  of  the dorsal  horn.  The  second order 
neurons  are  either  nociceptive specific  (substantia  gelatinosa)  or  wide dynamic 
range (WDR) neurons (in  laminae  V and VI)  that  respond to  a  wide range of 
noxious and non-noxious input. Both pathways ascend up the spinal cord via the 
spinothalamic  tracts  to  the  thalamus,  which  synapse  and  project  on  to  the 
somatosensory cortex. Inhibitory inter-neurons in the substantia gelatinosa prevent 
activation of the dorsal root ganglia. Interneurons can be activated by A beta and 
inhibited by A beta and C fibre activity. Pain can be gated-out by stimulating the 
large A beta fibres in the painful  area.  This is  the working mechanism behind 
transcutaneous electrical  nerve stimulation.  The descending inhibition pathways 
originate at the level of the cortex and thalamus, and descend via the brainstem 
(periaqueductal grey) and the dorsal columns to terminate at the dorsal horn of the 
spinal cord. Neurotransmitters noradrenaline, serotonin (5-HT) and the endogenous 
opioids are released to provide antinociception
12
1POST OPERATIVE PAIN
Effects of postoperative pain:
Postoperative pain can affect all organ systems and includes
Cardiovascular     - increased myocardial oxygen consumption which 
may  lead to ischemia.
Respiratory           - reduced cough, atelectasis, sputum retention and 
                                  hypoxemia.
Gastrointestinal    - delayed gastric emptying, reduced gut motility 
and  constipation.
Genitourinary       - urinary retention.
Neuroendocrine    - hyperglycemia, protein catabolism and sodium 
                                  retention.
Musculoskeletal    - reduced mobility, pressure sores and increased 
risk of  deep vein thrombosis.
Psychological        - anxiety and fatigue.
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Benefits of epidural analgesia
Use of postoperative epidural anaethaesia and analgesia especially with a 
local anaesthetic – based  analgesic solution can attenuate the pathophysiologic 
response  to  surgery  and  may  be  associated  with  a  reduction  in  mortality  and 
morbidity compared with analgesia with systemic opioids.
Rodgers et al( 19 ) demonstrated through a meta-analysis of randomized data 
that  perioperative  use  of  neuraxial  anaesthesia  and  analgesia  versus  general 
anaesthesia and systemic opioids reduced overall mortality by approximately 30%. 
Use  of  epidural  analgesia  can  decrease  the  incidence  of  postoperative 
gastrointestinal, pulmonary and cardiac complications.
Christopherson et al( 6 ) demonstrated that use of intra operative regional 
anaesthesia reduced  hypercoagulable – related events (eg. Deep vein thrombosis, 
pulmonary embolism, vascular graft failure).
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Postoperative analgesia in orthopaedics
Postoperative pain is of major concern after orthopaedic lower limb surgery. 
Moderate to severe at rest, it is exacerbated on movement and particularly after hip 
and  knee  surgery  and  by  severe  reflex  muscular  spasm.  This  not  only  causes 
patient  discomfort  but  also  compromises  the  early  physical  therapy,  the  most 
influential factor on rapid postoperative rehabilitation and ambulation. 
Postoperative pain relief can be achieved by a number of techniques such as 
intravenous patient controlled analgesia (PCA) with morphine or nonsteroidal anti-
inflammatory  drugs  or  epidural  analgesia.  Effective  analgesia  with  epidural  or 
peripheral block reduces narcotic requirements, provides better analgesia, reduces 
catabolism and results in improved rates of rehabilitation after orthopeadic lower 
limb surgeries.
The benefits  of  effective postoperative analgesia  in  orthopeadic  surgeries 
was made evident by the fact it facilitates early ambulation which is beneficial in 
the prophylaxis of deep vein thrombosis, which is a common problem encountered 
in orthopaedics( 20 ). Postoperative modalities like pneumatic compression boots, 
foot  pumps,  foot  exercises  and aspirin  can  be  safely  used  in  conjunction  with 
epidural anaesthesia to reduce the incidence of deep vein thrombosis.
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1BUPIVACAINE
Bupivacaine was introduced by Boaf Ekenstam in 1963
Chemical  structure: bupivacaine  hydrochloride  is  2-piperidenecarboxamide  1-
butyl-N-(2,6 dimethylphenyl) monochloride, a monohydrate is a white crystalline 
powder that is freely  soluble in 95% ethanol soluble in water and slightly soluble 
in chloroform or acetone.
It has the following structural formula:
Bupivacaine is related chemically and pharmacologically to the amide group 
of local anesthetics. It is structural homologues of mepivacaine.
Presentation: bupivacaine hydrochloride is  available in sterile isotonic solution 
with  or  without  epinephrine  1:2,00,000  for  injection.  0.25%,0.5%,0.75% 
concentration  containing  2.5mg/dl,  5mg/dl,  7.5mg/dl  of   bupivacaine 
hydrochloride  respectively.  Sodium chloride,  sodium hydroxide  ±  hydrochloric 
acid for pH adjustment. Methylparaben 1mg/ml added as preservative. 
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0.5%(hyperbaric ) solution contain 80mg/ml of glucose(with a specific gravity of 
1.026) - for intrathecal use.
Mechanism of action:
Local anaesthetics diffuse in their nonionized form through neural sheaths 
and the axonal membrane to the internal surface of the cell membrane sodium ion 
channels where they combine with hydrogen ions to form a cationic species which 
enters  the  internal  opening  of  the  sodium  ion  channel  and  combines  with  a 
receptor. This produces blockade of the sodium ion channels thereby decreasing 
sodium conductance and preventing depolarization of  the cell membrane.
Pharmacological action: 
a) Central nervous system(CNS):the principle effect of bupivacaine is reversible 
neural blockade, this leads to a characteristically biphasic effect on the CNS.
- Initially  excitation:  light  headness,  dizziness,  visual  and  auditory 
disturbances and seizures occurs due to blockade of inhibitory pathways in 
cortex.
- With  increasing  doses:  CNS  depression  occurs  depression  of  both 
facilitatory  and  inhibitory  pathways  leading  to  drowsiness  ,disorientation 
and coma.
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1- Local  anaesthetic  agents  block  neuromuscular  transmission  when 
administered  intra-arterially(formation  of   neurotransmitter,  receptor  and 
local anaesthetic complex which has negligible conductance).
b) Cardiovascular system (CVS): it binds specifically to myocardial proteins.In 
toxic  concentrations,the  drug  decreases  the  peripheral  vascular  resistance  and 
myocardial  contractility  producing  hypotension  and  possibly  cardiovascular 
collapse.
Routes of administration: topical, infiltration, intrathecal, epidural
Dose: 2mg/kg 
Pharmacokinetics:
Absorption : The absorption of local anaesthetic agent is related to
1. The site of injection (Intercostals> epidural> brachial plexus> subcutaneous)
2. The dose linear relationship exists between the total dose and the peak blood 
concentration achieved.
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Distribution: 95% protein bound in plasma. The volume of distribution is  47-103 
litres.
l
Metabolism: occurs in liver by N-dealkylation  primarily to pipcoloxylidine.   N-
desbutyl bupivacaine and 4-hyroxy bupivacaine are also formed.
Excretion : 5% of the dose is excreted in the urine as pipcolyloxylidine. 16% is 
excreted  unchanged .The  clearance  is  0.47  L/min  and  the  elimination  half  life 
(after intravenous administration) is 0.31-0.61 hours.
Pharmacodynamics:   pKa  of   bupivacaine  is  8.1.  Heptane:  Buffer  partition 
coefficient is 27.5.
                The onset and duration of conduction blockade is related to the pKa, 
lipid solubility and the extent of protein binding of the drug.
- A low pKa and high lipid solubility are associated with a rapid onset time.
- High degree of protein binding is associated with a long duration of action.
Toxicity /side effects:
i)  Allergic reactions to amide type local anaesthetics- extremely rare
19
ii) Intravascular injection can cause refractory cardiac depression .
I
CLONIDINE
Clonidine  hydrochloride  is  an  imidazoline  derivative  with  alpha  2- 
adrenergic  agonistic  activity  and  has  a  variety  of  different  actions  including 
antihypertensive  effects  as  well  as  the  ability  to  potentiate  the  effects  of  local 
anaesthetics.It can provide pain relief by an opioid-independent mechanism. 
STRUCTURE:
PREPARATIONS :       Oral  - 0.1/0.25/0.3 mg tablets
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Injections -  clear colourless solution containing        
    0.15mg/ml of Clonidine Hydrocloride 
                     
 
Mechanism of action:
- Stimulation of inhibitory α 2- adrenoreceptors to reduce central neural 
transmission in the spinal  neurons,thereby decreasing noradrenaline 
release from sympathetic nerve terminals and consequently decreasing 
sympathetic tone.
- Inhibition of  substance  P release is  believed to  be involved in  the 
analgesic. Some contribution to the analgesic effect of clonidine may 
be through release of acetylcholine in the neuraxial region. 
Pharmacological actions:
Cardiovascular system(CVS): when administered intravenously clonidine causes 
a  transient  increase  in the  blood pressure  (due  to  stimulation  of  vascular  α  1 
receptors) followed by a sustained decrease. The heart rate and venous return may 
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decrease slightly; the drug has no effect on cardiac contractility and cardiac output 
is well maintained. The systemic vascular resistance is decreased with long term 
treatment.
Central  Nervous  System(CNS):  clonidine  decreases  cerebral  blood  flow  and 
intraocular pressure. It exerts a depressant effect on both spontaneous sympathetic 
outflow and afferent Aδ and C- fibre mediated somatosympathetic reflexes.
o
Autonomic system: clonidine decreases gastric and small bowel motility and is an 
antisialogogue.
Genitourinary system: clonidine reduces renovascular resistance ; however little 
alteration in the glomerular filtration rate occurs.
Pharmacokinetics:
Absorption: the drug is rapidly and well absorbed when administered  orally; the 
oral bioavailability is 100%.
Distribution: clonidine is  well  lipid soluble  and penetrates  the central  nervous 
system. The drug is 20% protein bound in the plasma; the volume of distribution is 
1.7-2.5 L/kg.
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Metabolism: less than half of an administered dose is metabolized in the liver to 
inactive metabolites.
Excretion: 65% of the dose of clonidine is excreted unchanged in the urine;  some 
20%  is  excreted  in  the  faeces.  The  clearance   is  1.9-4.3  ml/min/kg  and  the 
elimination half life is 6-23 hours. The latter is markedly increased in the presence 
of renal impairment; the dose of clonidine should be reduced if  the glomerular 
filtration rate is  < 10ml/min.
f
Toxicity  /  side  effects:  drowsiness,  dry  mouth,  fluid  retention,  impotence  and 
constipation. Rapid withdrawal of the drug may lead to life-threatening rebound 
hypertension and tachycardia.
USES:
- To prolong the duration of epidural/spinal anaesthesia
- Epidural add on agent for relief of severe cancer pain and 
intra - articular pain
- As anxiolytic 
-  For sedation
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- To prevent &/or treat shivering
24
REVIEW OF LITERATURE
1. Epidural clonidine analgesia for intractable cancer pain.
Eisenach JC, et al in 1995,conducted a randomized control study in Eighty-
five patients with severe cancer pain despite large doses of opioids or with therapy-
limiting side effects  from opioids.  The patients were randomized to recieve 30 
micrograms/h  epidural  clonidine  or  placebo  for  14  days,  together  with  rescue 
epidural morphine. Pain was assessed by visual analog score (VAS), McGill Pain 
Questionnaire, and daily epidural morphine use. Success was defined as a decrease 
in either morphine use of VAS pain, with the alternative variable either decreasing 
or  remaining  constant.  Blood  pressure,  heart  rate,  and  degree  of  nausea  and 
sedation were monitored. Successful analgesia was more common with epidural 
clonidine (45%) than with placebo (21%). This was particularly prominent in those 
with neuropathic pain (56% vs.  5%). Pain scores were lower at the end of the 
treatment  period in patients  with neuropathic  pain treated with clonidine rather 
than placebo, whereas morphine use was unaffected. Clonidine, but not placebo, 
decreased blood pressure  and heart  rate.  Hypotension was considered a serious 
complication in 2 patients receiving clonidine and in 1 patient receiving placebo. 
This study confirmed the findings from previous animal studies which showed the 
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effective, potent analgesic properties of intraspinal alpha 2-adrenergic agonists and 
suggests that 
epidural clonidine may provide effective relief for intractable cancer pain, 
particular of the neuropathic type.
2.  Hemodynamic and analgesic profile after intrathecal clonidine in  humans. 
Filos.KS , et al in 1995, performed a study to evaluate the dose-response 
hemodynamic and analgesic profiles of intrathecal clonidine administered after a 
standard surgical intervention, without perioperative administration of additional 
analgesics,  local  anesthetics  or  tranquilizers.  METHODS:  In  a  randomized 
prospective  double-blind  study,  30  women  who  underwent  elective  cesarean 
section  during  general  anesthesia  with  thiopental,  nitrous  oxide,  and  halothane 
were  studied.  Forty-five  minutes  after  tracheal  extubation,  a  lumbar  intrathecal 
puncture was performed, and the patients received 150 (group 1), 300 (group 2), or 
450 (group 3) micrograms clonidine. Postoperative analgesia was assessed on a 
visual analog scale at rest and after deep cough at standard time points up to 24 h. 
The results demonstrated the dose-dependent analgesia after intrathecal clonidine 
at  doses  as  great  as  450  micrograms.  The  nearly  immediate  analgesic  effect 
observed after intrathecal injection of  300 and 450 micrograms clonidine strongly 
argues for a spinal rather than a systemic site of action of this alpha 2-adrenergic 
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agonist.  After  300  and  450  micrograms  intrathecal  clonidine  a  relative 
hemodynamic stability is observed, suggesting a pressor effect at peripheral sites.
h
3.  Spinal administration of alpha 2-adrenoceptor agonists and opioids or local 
anaesthetic agent.                                                                        
Motsch J,et al in 1996, extensively studied the effects of combined spinal 
administration of alpha(2)-adrenoceptor agonists, local anaesthetics, and opioids. 
The motor and the sensory block of spinal and epidural anaesthesia is enhanced 
and  prolonged  by  the  combination  of  clonidine  with  the  local  anaesthetics 
lidocaine,  tetracaine  and  bupivacaine.  Because  higher  plasma  levels  of  local 
anaesthetics  were  measured  when  clonidine  was  injected  epidurally,  the 
enhancement of the local anaesthetic’s effect by clonidine is not due to slowed 
resorption,  but  rather  to  direct  spinal  and  supraspinal  effects  of  clonidine. 
Furthermore, direct local anaesthetic properties of clonidine on nerve fibres are 
discussed. Circulatory effects of combined clonidine and local anaesthetics are the 
result  of  the  specific  spinal  blockade  and the  central  and peripheral  effects  of 
clonidine.  In  humans,  the  interaction  seems  to  be  additive  rather  than  supra-
additive.  Neither the incidence nor the severity of side effects is increased by a 
combined therapy with opioids. Despite the sedative properties of clonidine, there 
is  no  increased  risk  of  respiratory  depression  when  clonidine  is  given  in 
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combination with opioids. The inhibiting effect on the sympathetic nervous system 
activity regularly observed during spinal administration of clonidine supports the 
value  of  this  therapy  and  will  support  its  use  in  the  future.  Therefore,  the 
combination of alpha(2)-adrenoceptor 
agonists with local anaesthetics or opioids is reasonable and may improve 
anaesthetic practice.
4.   Epidural  clonidine  used  as  the  sole  analgesic  agent  during  and  after 
abdominal surgery. 
De Cock Em , et al in 1997, investigated the analgesic potency of epidural 
clonidine when used as the sole analgesic agent during and after major abdominal 
surgery.  Fifty young adult patients undergoing intestinal surgery under general 
anesthesia  with  propofol  were  studied.  At  induction,  the  patients  received 
epidurally  either  an initial  dose of   2 micrograms/kg clonidine followed by an 
infusion of  0.5 microgram/kg/h (group 1, n = 10) or 4 micrograms/kg followed by 
1 microgram/kg/h (group 2, n = 20) or 8 micrograms/kg/h followed by an infusion 
of  2 micrograms/kg/h (group 3, n = 20). By this study they demonstrated that 
Epidural  clonidine  used  as  the  sole  analgesic  agent  provided  dose-dependent 
control of the hemodynamic changes associated with surgical stimulation. It also 
produced dose-dependent postoperative analgesia without major side effects.
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5.    Reduction of  postoperative mortality  and morbidity with epidural   or 
spinal anaesthesia: results from overview of randomised trials 
Anthony Rodgers,et  al  in  2000  ,conducted  a  study  to  obtain  reliable 
estimates of the effects of neuraxial blockade with epidural or spinal 
anaesthesia  on postoperative morbidity  and mortality.  141 trials including 
9559 patients  for  which data  were  available  before  1 January  1997. Trials  were 
eligible irrespective of their primary aims, concomitant use of general anaesthesia, 
publication status, or language. Results: Overall mortality was reduced by about a 
third in patients allocated to neuraxial blockade (103 deaths/4871 patients versus 
144/4688  patients,  odds  ratio=0.70,  95%  confidence  interval 0.54 to 
0.90, P=0.006). Neuraxial blockade reduced the odds of deep vein thrombosis by 
44%, pulmonary embolism by 55%, transfusion requirements by 50%, pneumonia 
by  39%,  and  respiratory  depression by  59%  (all  P<0.001).  There  were  also 
reductions in myocardial infarction and renal failure. Although there was limited 
power to assess subgroup effects, the proportional reductions in mortality did not 
clearly differ by surgical group, type of blockade (epidural or spinal), or in those 
trials  in  which  neuraxial  blockade  was combined  with  general  anaesthesia 
compared with trials in which neuraxial blockade was used alone.  Conclusions: 
Neuraxial  blockade  reduces  postoperative  mortality and  other  serious 
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complications. The size of some of these benefits remains uncertain, and further 
research is required to determine whether these effects are due solely to benefits of 
neuraxial blockade  or  partly  to  avoidance  of  general  anaesthesia.  Nevertheless, 
these findings support more widespread use of neuraxial blockade.
b
6. Effects of Clonidine combined with small dose bupivacaine during spinal 
anaesthesia for inguinal herniorraphy
I.Dobrydnjov and H.Klockoff,  et  al  in 2003,  demonstrated the different 
actions  of   clonidine  including  the  ability  to  potentiate  the  effects  of  local 
anaesthetics. 45 patients, ASA physical status I-II, age >20 yr, who underwent 
open inguinal herniorrhaphy as a day case procedure were recruited for the study. 
The following drug combinations were slowly injected intrathecally over 3 min. 
patients in Group B received 6 mg of bupivacaine in 8% glucose, patients in 
Group BC15 received 6 mg of bupivacaine in 8% glucose and 15µg of clonidine 
and patients in Group BC30 received 6mg of bupivacaine in 8% glucose and 30 
µg of clonidine. All test solutions were diluted with saline to total volume of 3 
ml. they concluded that the study has shown that the use of clonidine as adjuvant 
to  small  dose  (6  mg)  bupivacaine  is  effective  for  ambulatory  inguinal 
herniorrhaphy. The addition of intrathecal clonidine 15µg or 30 µg to small dose 
bupivacaine  increased  the  spread  and  duration  of  analgesia  and  produced an 
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effective spinal anaesthesia. Clonidine 15 µg combined with bupivacaine 6 mg in 
8%  glucose  did  not  produce  prolonged  postoperative  motor  block  and  is 
therefore to be preferred for ambulatory inguinal herniorraphy.   
7.  Comparison Of The Verbal Rating Scale And The Visual Analog Scale 
For Pain Assessment              
           Randall C. Cork,et al in 2004, performed a survey to determine if the 
simple Verbal Rating Scale (VRS) could be substituted for the Visual Analog 
Scale (VAS) to measure pain intensity in chronic pain patients. Eighty-five (85) 
chronic  pain  patients  were  surveyed  using  both  VAS  and  VRS.  Pearson 
correlation  coefficient(r  =  0.906)  and  p  value  (<  0.0001)  showed  excellent 
correlation between the two, although VRS showed a tendency to be higher than 
VAS (p=0.068). They proposed that the VRS provided a useful alternative to the 
VAS scores in assessment of chronic pain. Eighty-five consecutive chronic pain 
patients  who  presented  at  the  Pain  Management  Service  at  Louisiana  State 
University Health Sciences Center, Shreveport (LSUHSC-S) were surveyed. A 
physician  interviewed  the  patient  and  filled  out  survey  forms.  Patients  were 
asked to rate their pain with the VAS and the VRS. The VRS as described above 
is easily assessed, takes less time than the VAS, and can be performed without 
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the need of paper and pen. It is relatively simple to understand and thus provides 
a correlation which is more definitive than a distance mark. Their analysis took a 
measurement engineering approach by 
looking  at  the  reliability  and  validity  of  VRS,  using  VAS  as  the  standard. 
Reliability is assessed with an analysis of correlation, while validity is assessed 
with Student's t-test for paired data. The VRS is a simple instrument that can 
save time and can be compared favorably to the VAS.
8. Epidural Clonidine for postoperative pain after Total Knee Arthroplasty: 
A Dose-Response Study. 
         Huang.Y,et al in 2007, conducted a randomized double-blind study  to 
evaluate  the optimal  epidural  dose of  clonidine administrated after  total  knee 
arthroplasty  (TKA) in  Eighty  adult  patients.  Methods:   All the  patients  were 
randomly assigned to one of four study groups (C0, C1, C2, C4), 20 patients 
each. After surgery, group C1, C2 and C4 patients received patient-controlled 
epidural analgesia (PCEA) with morphine (0.1 mg/mL) and clonidine (1, 2, 4 µg/
mL, respectively) in 0.2% ropivacaine 100 mL, while group C0 patients received 
only  PCEA  morphine  (0.1  mg/mL)  and  0.2%  ropivacaine for  postoperative 
control.  Pain relief was evaluated by the total  PCEA consumption and visual 
analog scale. Systolic blood pressure (SBP), heart rate (HR), sedation, sensory 
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and motor blockade  were  also  recorded during  the  72 h  postoperatively. The 
degree of knee  flexion was also recorded daily until discharge. Results: Group 
C0, C1, C2 and C4 patients requested 71.8±19.5, 
 
49.6±12.3,  48.1±9.3  and  39.4±9.0  mL  respectively. Patients  in  the  clonidine 
groups experienced less  postoperative pain during the 72 hours after  surgery. 
Discussion: The concentration of clonidine 1 µg/mL mixture with morphine and 
ropivacaine has to be considered the optimal epidural dose. The higher dose of 
epidural  clonidine  (4  µg/mL) produced  the  best  analgesia  but  the  degree  of 
sedation and sensory blockade were more severe and longer lasting; it required 
careful monitoring of the patient.
9. Epidural fentanyl-bupivacaine compared with clonidine-bupivacaine for 
analgesia in labour
           S. Kizilarslan, et al in 2006, demonstrated that  Alpha-adrenergic agonists 
produce  pain  relief  through  an  opioid  independent  mechanism  and  may  be 
alternatives  to  opioids  for  combination  with  local  anaesthetics  for  analgesia 
during labour. He studied 41 pregnant women. Epidural block was performed 
with 75 μg clonidine (n=20) or 50 μg fentanyl (n=21) combined with 0.125% 
bupivacaine (10 Ml). Maternal vital parameters were measured. Analgesia was 
evaluated using a visual analogue scale (VAS); sedation was scored using a five-
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point scale. There were no differences in maternal vital parameters, fetal heart 
rate (FHR) or Apgar scores between the groups. Analgesia lasted longer in the 
bupivacaine-clonidine group (139.4±31 min)  compared with the bupivacaine–
fentanyl group (127.9±48 min) (P=0.42). Additional analgesic 
requirement  was  more  often  in  the  fentanyl–bupivacaine  group  and  total 
bupivacaine  requirement  was  less  in  the  clonidine–bupivacaine  group 
(22.5±12.5mg  vs.  30.9±12.8  mg)  (P=0.04).  This  study  confirmed  that  the 
combination  of  bupivacaine  and  clonidine  provides  satisfactory  analgesia  for 
first-stage labour, and of longer duration than bupivacaine–fentanyl.
10. Effect of addition of intrathecal clonidine to hyperbaric bupivacaine on 
postoperative pain and morphine requirements after Caesarean section
         I.van Tuijl , et al in 2006, demonstrated that the addition of clonidine(75 
µg)  to  hyperbaric  bupivacaine  prolongs  the  duration  of  spinal  analgesia  and 
reduces  the  need  for  postoperative  self-  administration  of  i.v.morphine  after 
caesarean section by conducting a randomized controlled double-blind trial. The 
study  was  done  in  healthy  women(ASA  I  or  II)  presenting  for  an  elective 
caesarean  section  from  a  group  of  209  candidates.  Patients  were  randomly 
allocated to receive spinal anaesthesia using either bupivacaine 0.5% (2.2 ml) 
heavy with 0.5 ml normal saline 0.9% (total- 2.7 ml) (Group B) or bupivacaine 
0.5% (2.2 ml) heavy with clonidine (75 µg) in 0.5 ml normal saline 0.9% (2.7 
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ml) (Group BC). Spinal anaesthesia was performed using a 25-gauge pencil point 
needle with the patient in the sitting position at the lumbar 3-4 interspace. They 
concluded that addition of 75 µg clonidine to hyperbaric bupivacaine prolongs 
spinal analgesia and the motor block after Caesarean section and 
improves early analgesia. In this study, this effect was obtained without clinically 
relevant maternal or neonatal side effects.
11. Epidural clonidine added to a bupivacaine infusion increases analgesic 
duration in labor without adverse maternal or fetal effects
        Robert K. Parker,et al in 2007, conducted a study to determine the potential 
for maximizing the time to first epidural supplement when adding clonidine to a 
0.625 mg·ml−1 bupivacaine  continuous  epidural  infusion  following  epidural 
fentanyl bolus in early labor for patients allowed to ambulate. Maternal and fetal 
effects  secondary  to  clonidine  were  also  evaluated.  Methods : Sixty-eight 
laboring primigravid women received a 3-ml epidural test dose of  lidocaine with 
epinephrine,  followed  by  a  fentanyl  100-µg  bolus  (in  a  10 ml-volume).  The 
patients then received a 0.625 mg·ml−1 bupivacaine continuous epidural infusion, 
either with or without clonidine (5 µg·ml−1), at a rate of 10 ml·h−1. Pain scores and 
side  effects  were  recorded  for  each  patient.  Results : The  overall  quality  of 
analgesia was similar  in both groups.  The mean duration prior  to request  for 
additional analgesia was significantly longer in the clonidine group (269 ± 160 
min), compared to the control group (164 ± 64 min). No patient in either group 
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experienced  any  detectable  motor  block;  one  patient  (clonidine  group) 
complained of mild thigh 
numbness and was not  allowed to ambulate.  While mean blood pressure was 
approximately 6 mmHg lower in the clonidine group at 1, 1.5, and 3.5 h, this was 
not clinically significant. No adverse effects on maternal heart rate or fetal heart 
rate  were noted.  Conclusion : In  early  laboring patients,  addition of  clonidine 
prolonged  the  analgesia  duration  of  a  0.625 mg·ml−1 bupivacaine  continuous 
epidural  infusion  following  100 µg  epidural  fentanyl  (after  a  lidocaine-
epinephrine test dose) without a clinically significant increase in side effects.
e
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MATERIALS AND METHODS
Patient selection:
         The study population consist of ASA I & ASA II patients in the age group 
of  18 years  to  65 years  admitted to undergo elective orthopaedic  lower limb 
surgeries at Govt. Stanley Hospital, Chennai during the period of January 2008 
to June 2008. After getting approval by the institutional ethical committee and 
after  obtaining  written  informed  consent  from  each  patient  ,the  study  was 
conducted.
Inclusion criteria:
1. Age Group 18 – 65 years
2. ASA I and ASA II
3. Elective orthopaedic lower limb surgeries
4. Duration of Surgery between 2:00 to 2:30 hours.
Exclusion criteria: 
     1.  Patient refusal      
     2.  Age < 18 years and age > 65years
37
     3.  ASA III and ASA IV
 
     4. Patient posted for emergency surgery.
     5.  Ischemic heart disease/ rheumatic heart disease
     6.  Sinus bradycardia / heart blocks / conduction defects
     7.  Preoperative hypotension
     8.  Local infection at lumbar area
     9.  Pre-existing neurological disorders
    10.  Coagulation defects and patient on anticoagulants 
Preoperative assessment:
         -   Routine clinical examination
         -   Biochemical investigations,
         -   Electrocardiogram and chest x-ray were examined thoroughly for 
              the conduct of   anaesthesia.
Conduct of anaesthesia:
         Patients were allocated randomly into two equal  groups (20 in each 
group).Group P (placebo)  received 1 ml of normal  saline with the first dose of 
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epidural 0.5%   bupivacaine. Group C (clonidine) received 50µg of clonidine 
diluted  with  normal  saline  to  1  ml  epidurally  along  with  the  first  dose  of 
bupivacaine.
        No premedication was given. On arrival in the operating room, baseline 
cardiorespiratory parameters viz., Heart Rate(HR), Systolic blood pressure(SBP), 
Diastolic  blood  pressure(DBP),Mean  arterial  pressure(MAP)  and  Respiratory 
rate(RR) were recorded.
         A good intravenous  access  was  established using  18G IV cannula. 
Preloading was done with crystalloids (10 ml/kg).
         With the patient in sitting posture, after informing the procedure to the 
patient & under strict aseptic precautions, epidural space was identified at L3-L4 
interspace using 17G Tuohy needle by loss of resistance technique. 19G epidural 
catheter was threaded in a cephalad direction & 4 cm catheter length was kept 
inside the epidural space. A test dose of 3 cc of 1.5 % lignocaine with adrenaline 
(5 µg/ml)  was  given.After  confirming negative  result  for   test  dose,  epidural 
catheter was fixed and secured with tapes.  A standard anaesthetic technique was 
followed in all patients.
39
Epidural 1st dose   -   14 ml of 0.5% bupivacaine + 1ml of placebo or 50 µg of 
injection clonidine diluted with normal saline to 1 ml. 
 Epidural 2nd dose -    6ml of 0.5% bupivacaine (90 mins after 1st dose) 
 
          Patients with duration of surgery between 2-2:30 hours requiring standard 
2  doses  of  epidural  local  anaesthetics  were  only  taken  up  for  study. 
Unanticipated prolonged duration of surgery ( requiring more than 2 doses) were 
excluded from the study.
          Time of incision was noted.
          Intra-operatively the patient was monitored with ECG, BP and SpO2.
          The following parameters were continuously monitored and noted every 
10 mins:
   1. Heart rate (HR)
   2. Systolic blood pressure (SBP)
   3. Diastolic blood pressure (DBP)
   4. Mean arterial pressure (MAP)
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   5. Respiratory rate (RR)
   -  Ramsay sedation scale (RSS) was also noted every 30 min.
          All patients were given oxygen supplementation (4-5 L/min) through 
Hudson’s  face  mask.  No  intravenous  opioid  analgesics  were  supplemented 
during the study. Intravenous fluid management was done based on Mean arterial 
blood pressure and surgical blood loss.
RAMSAY SEDATION SCALE:
1.  Patient is anxious and agitated or restless, or both.
2.  Patient is co-operative, oriented and tranquil.
3.  Patient responds to commands only.
4.  Patient exhibits brisk response to light glabellar tap or loud auditory stimulus.
5.  Patient exhibits a sluggish response to light glabellar tap or loud  auditory 
stimulus. 
6.  Patient exhibits no response.
POST- OPERATIVE MONITORING :
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          The epidural catheter was retained in position. Postoperatively the patient 
was transferred to the Post Anaesthetic Care Unit( PACU) where PR,SBP ,DBP, 
SPO2 & RR  monitored continuously and recorded every hour. 
          The intensity of pain was measured by using the verbal rating pain scale.
T
Pain Score (Verbal Rating Score):
Grade 0  - No complaint of pain
Grade 1  - Patient complaints of pain but tolerable (mild pain)
Grade 2  - Patient complaining of severe pain and demands relief 
                 (Moderate pain) 
Grade 3  - Patient restless and screaming with pain(Severe pain)
          When the patient complained of pain , the pain intensity was assessed 
based on verbal rating scale & if pain score reaches 1, epidural top up of  6ml of 
0.125% bupivacaine was given to the patient.
          The time of first rescue analgesia(TFA) was calculated from the time of 
injection of study drug in the epidural space to the time when the verbal rating 
pain score reached 1 in the post-operative period. 
          Number of epidural top-ups (6 ml of 0.125% bupivacaine) required by 
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each patient for a period of 48 hours was noted in both the groups.
LIST OF ORTHOPAEDIC LOWER LIMB SURGERIES
S.NO
DIAGNOSIS AND SURGICAL 
PROCEDURES
NO. OF CASES
GROUP P GROUP C
1. Fracture shaft of femur- ORIF with 
interlocking nailing
8 10
2. Fracture both bones leg- ORIF with 
intramedullary nailing
6 5
3. Fracture neck of femur- Hemiarthroplasty 3 2
4. Supracondylar fracture femur – ORIF with 
Dynamic Condylar Screw (DCS)
2 3
5. Fracture Patella- ORIF with Tension Band 
Wiring
1 -
                                   TOTAL CASES 20 20
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OBSERVATIONS
STATISTICS AND ANALYSIS: 
Forty patients posted for orthopaedic lower limb surgeries of ASA I and 
ASA II were taken up for the study. They were allocated randomly into two equal 
groups of 20 each. Group P receieved 1 ml of placebo along with the first dose of 
epidural 0.5% bupivacaine and Group C received 50 µg of clonidine diluted with 
normal  saline  to  1  ml  along  with  first  dose  of  epidural  0.5% bupivacaine.  A 
standard  anaesthetic  technique  was  followed  in  all  patients.  The  patients  were 
assessed by the same observer in the postoperative period.
           All the data were expressed as mean ± standard deviation (SD). Qualitative 
variables were compared with  ‘Chi-square test’ and quantitative variables were 
compared with ‘the student ‘t’ test’. The level of statistical significance was set at 
P < 0.05.
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4DEMOGRAPHIC PROFILE:
TABLE- 1-Comparison of age distribution
S.NO PARAMETERS GROUP P VALUE
GROUP P GROUP C
MEAN ± SD MEAN ± SD
1. Age (yrs) 40.60 ± 7.40 36.85 ± 9.59 P-0.183(NOT 
SIGNIFICANT)
Figure 1: BOX- PLOT compares the age distribution of GROUP P and GROUP C
The age distribution was comparable between the two groups, P value not 
significant.
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TABLE – 2
SEX DISTRIBUTION                 
 
            The P value for sex distribution is 0.695 – Not Significant. 
FIGURE -2
SEX DISTRIBUTION
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TABLE -3
Comparison of Height and Weight
S.NO PARAMETERS GROUP P value
GROUP P GROUP C
MEAN±SD MEAN±SD
1. HEIGHT(cms) 164.00±5.73 166.65±6.01 P-0.152(Not 
Significant)
2. WEIGHT(kgs) 59.60±5.16 59.50±6.10 P-0.956(Not 
Significant)
FIGURE -3
HEIGHT AND WEIGHT
There was no significant difference in Height and Weight 
between the two groups.
TABLE- 4
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DURATION OF SURGERY
GROUP P GROUP C P VALUE
DURATION OF 
SURGERY(HRS)
2.14 ± 0.07 2.12 ± 0.07
P – 0.359
NOT 
SIGNIFICANT
There was no significant difference in the duration of surgery (hrs) between the 
two groups.
FIGURE -4
DURATION OF SURGERY (HRS)
D
TABLE- 5
HEART RATE
S 
NO.
PARAMETERS
(MINUTES)
GROUP P VALUE
P<0.05-SIGGROUP P GROUP C
MEAN ± SD MEAN ± SD
1. HR PRE-OP 94.10 ± 11.81 97.05 ± 12.81 .441(NOT SIG)
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2. HR10 92.20 ± 8.16 94.70 ± 11.69 .438(NOT SIG)
3. HR20 88.90 ± 8.70 90.40 ± 12.12 .656(NOT SIG)
4. HR30 85.95 ± 7.52 87.30 ± 11.77 .668(NOT SIG)
5. HR40 84.80 ± 8.29 87.10 ± 12.81 .504(NOT SIG)
6. HR50 83.85 ± 8.34 85.45 ± 13.03 .646(NOT SIG)
7. HR60 82.75 ± 8.66 84.90 ± 11.79 .515(NOT SIG)
8. HR70 81.95 ± 9.24 82.55 ± 10.73 .851(NOT SIG)
9. HR80 82.35 ± 8.96 81.65 ± 9.9.52 .812(NOT SIG)
10. HR90 83.00 ± 9.59 82.00 ± 11.94 .908(NOT SIG)
11. HR100 84.55 ± 9.02 83.6 ± 10.51 .761(NOT SIG)
12. HR110 86.30 ± 7.55 85.7 ± 10.26 .834(NOT SIG)
13. HR120 84.15 ± 10.00 86.85 ± 10.21 .594(NOT SIG)
14. HR130 87.30 ± 8.41 86.20 ± 10.28 .713(NOT SIG)
15. HR140 87.00 ± 8.60 88.65 ± 11.08 .602(NOT SIG)
16. HR150 90.70 ± 8.98 90.70 ± 10.53 1.00(NOT SIG)
1
TABLE -6
SYSTOLIC BLOOD PRESSURE
S PARAMETERS GROUP P VALUE
49
NO. (MINUTES)
P<0.05- SIGGROUP P GROUP C
MEAN ± SD MEAN ± SD
1. SBP PRE-OP 128.80 ± 6.68 130.20 ± 6.47 0.505(NOT SIG)
2. SBP 10 120.20 ± 11.70 118.65 ± 5.85 0.600(NOT SIG)
3. SBP 20 110.05  ± 11.64 107.40 ± 10.88 0.462(NOT SIG)
4. SBP 30 113.85 ± 13.51 112.70 ± 6.85 0.736(NOT SIG)
5. SBP 40 114.90 ± 9.29 108.30 ± 22.37 0.231(NOT SIG)
6. SBP 50 116.00 ± 8.57 111.05 ± 7.16 0.055(NOT SIG)
7. SBP 60 115.70 ± 9.81 110.25 ± 5.98 0.041(SIG)
8. SBP 70 116.00 ± 7.38 108.70 ± 8.97 0.008(SIG)
9. SBP 80 114.80 ± 7.96 112.95 ± 7.51 0.454(NOT SIG)
10. SBP 90 114.50 ± 7.04 111.80 ± 8.47 0.280(NOT SIG)
11. SBP 100 113.65 ± 8.56 110.35 ± 7.88 0.212(NOT SIG)
12. SBP 110 118.35 ± 5.38 112.45 ± 7.30 0.006(SIG)
13. SBP 120 120.35 ± 5.33 113.75 ± 8.90 0.007(SIG)
14. SBP 130 117.55 ± 5.05 113.00 ± 8.37 0.044(SIG)
15. SBP 140 118.70 ± 6.34 114.80 ± 7.46 0.083(NOT SIG)
16. SBP 150 124.10 ± 3.74 120.00 ± 8.03 0.045(SIG)
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FIGURE – 5
HEART RATE
P-value is not significant among both the groups at any 
point of time during  intra-operative heart rate monitoring.
                                                      FIGURE – 6
SYSTOLIC BLOOD PRESSURE
Systolic blood pressure monitoring between two groups were found to be 
insignificant except during 70, 110, 120, 130, 150 minutes.
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TABLE – 7
DIASTOLIC BLOOD PRESSURE
S 
NO.
PARAMETERS 
(MINUTES)
GROUP
P VALUE
P<0.05- SIG
GROUP P GROUP C
MEAN ± SD MEAN ± SD
1. DBP PRE OP 82.40 ± 3.01 81.85 ± 4.93 0.673(NOT SIG)
2. DBP 10 75.20 ± 8.70 74.00± 6.02 0.615(NOT SIG)
3. DBP 20 68.15± 10.38 65.50 ± 10.18 0.420(NOT SIG)
4. DBP 30 69.40 ± 9.63 69.15 ± 6.36 0.923(NOT SIG)
5. DBP 40 71.60 ± 7.80 67.65 ± 15.14 0.306(NOT SIG)
6. DBP 50 72.20 ± 8.35 68.70 ± 4.47 0.107(NOT SIG)
7. DBP 60 73.20 ± 7.88 67.85 ± 3.74 0.009(SIG)
8. DBP 70 72.55 ± 7.75 66.95 ± 5.60 0.013(SIG)
9. DBP 80 71.75 ± 6.48 70.70± 4.95 0.568(NOT SIG)
10 DBP 90 72.65 ± 6.55 69.45 ± 4.87 0.088(NOT SIG)
11. DBP 100 72.50 ± 7.49 69.85 ± 5.54 0.211(NOT SIG)
12. DBP 110 74.30 ± 5.10 70.45 ± 4.42 0.015(SIG)
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13. DBP 120 75.35 ± 6.67 71.85 ± 5.61 0.080(NOT SIG)
14. DBP 130 73.30 ± 5.19 70.95 ± 5.07 0.156(NOT SIG)
15. DBP 140 74.90 ± 6.20 71.65 ± 4.33 0.062(NOT SIG)
16. DBP 150 79.15 ± 3.04 78.10 ± 4.61 0.401(NOT SIG)
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TABLE- 8
MEAN ARTERIAL PRESSURE
S 
NO.
PARAMETERS 
(MINUTES)
GROUP P VALUE
P<0.05- SIG
GROUP P GROUP C
MEAN ± SD MEAN ± SD
1. MAP PRE OP 97.85 ± 3.51 97.90 ± 4.74 0.970(NOT SIG)
2. MAP 10 90.40 ± 9.34 88.80 ± 5.61 0.516(NOT SIG)
3. MAP 20 81.85 ± 10.05 78.85 ± 10.35 0.359(NOT SIG)
4. MAP 30 83.85 ± 9.94 83.80 ± 5.52 0.984(NOT SIG)
5. MAP 40 86.20 ± 8.15 84.65 ± 4.58 0.463(NOT SIG)
6. MAP 50 86.70 ± 8.15 83.00 ± 4.66 0.086(NOT SIG)
7. MAP 60 88.25 ± 8.97 82.05 ± 4.31 0.008(SIG)
8. MAP 70 86.90 ± 7.38 80.85 ± 6.44 0.009(SIG)
9. MAP 80 86.00 ± 6.58 84.70 ± 5.55 0.504(NOT SIG)
10. MAP 90 86.40 ± 6.32 83.45± 5.77 0.132(NOT SIG)
11. MAP 100 85.85 ± 7.76 83.65± 5.31 0.302(NOT SIG)
12. MAP 110 89.35 ± 5.30 84.60 ± 5.04 0.006(SIG)
13. MAP 120 89.80 ± 6.13 85.85 ± 6.22 0.050(NOT SIG)
14. MAP 130 88.25 ± 4.35 85.05 ± 5.79 0.055(NOT SIG)
15. MAP 140 88.90 ± 6.07 86.20 ± 4.80 0.127(NOT SIG)
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16. MAP 150 94.00 ± 2.95 91.75 ± 5.15 0.098(NOT SIG)
0
FIGURE -7
DIASTOLIC BLOOD PRESSURE
Intra-operative Diastolic Blood Pressure monitoring between the two groups were 
found to be insignificant except during 60, 70 and 110 minutes.
FIGURE -8
MEAN ARTERIAL PRESSURE
Intra-operative Mean Arterial Pressure monitoring between the two groups were 
found to be insignificant except during 60, 70 and 110 minutes.
f
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TABLE- 9
RESPIRATORY RATE
S 
NO.
PARAMETERS 
(MINUTES)
GROUP
P VALUE
P<0.05- SIG
GROUP P GROUP C
MEAN ± SD MEAN ± SD
1. RR PRE OP 15.80 ± 1.58 19.75 ± 1.56 0.268(NOT SIG)
2. RR 10 14.45 ± 1.47 15.20 ± 1.28 0.093(NOT SIG)
3. RR 20 14.65 ± 1.87 15.10 ± 1.41 0.396(NOT SIG)
4. RR 30 14.40 ± 2.37 14.55 ± 1.76 0.822(NOT SIG)
5. RR 40 14.10 ± 2.04 14.30 ± 1.45 0.724(NOT SIG)
6. RR 50 14.25 ± 1.58 14.30 ± 1.49 0.919(NOT SIG)
7. RR 60 14.45 ± 2.01 14.45±1.27 1.000(NOT SIG)
8. RR 70 14.55 ± 2.44 14.65 ± 1.27 0.872(NOT SIG)
9. RR 80 14.70 ± 2.12 14.85 ± 1.35 0.792(NOT SIG)
10 RR 90 14.50 ± 1.76 14.35 ± 1.56 0.777(NOT SIG)
11. RR 100 14.60 ± 1.50 14.35 ± 1.35 0.583(NOT SIG)
12. RR 110 14.80 ± 1.73 14.40 ± 1.53 0.445(NOT SIG)
13. RR 120 14.75 ± 2.07 14.80 ± 1.05 0.923(NOT SIG)
14. RR 130 15.50 ± 2.91 15.00 ± 1.17 0.480(NOT SIG)
15. RR 140 14.95± 1.47 14.90 ± 0.97 0.899(NOT SIG)
16. RR 150 15.00 ± 1.45 15.05 ± 0.99 0.900(NOT SIG)
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ðTABLE -10
RAMSAY SEDATION SCALE
TIME(min) RSS GROUP P GROUP C TOTAL
30
1. COUNT
%WITH IN 
GROUP
20
100%
12
60%
32
80%
2.  COUNT
                  %WITH IN
                  GROUP
0
0%
8
40%
8
20%
60
1.       COUNT
 %WITH IN
                  GROUP
20
100%
0
0%
20
50%
2.       COUNT
                  %WITH IN 
                  GROUP
0
0%
20
100%
20
50%
90
1.       COUNT
 %WITH IN
 GROUP
20
100%
6
30%
26
65%
2.       COUNT
                  %WITH IN 
                  GROUP
0
0%
14
70%
14
35%
120
1.       COUNT
 %WITH IN
                  GROUP
20
100%
19
95%
39
97.5%
2.       COUNT
                  %WITH IN
                  GROUP
0
0%
1
5%
1
2.5
150
1          COUNT
 %WITH IN
                    GROUP
20
100%
20
100%
40
100%
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    According to Chi- square test, RSS was significant at 30 min (P-0.003), 60 min 
(P<0.001) and 90 min (P<0.001). RSS was not significant at 120 min and 150 min 
respectively.
r
FIGURE – 9
RESPIRATORY RATE
There was no significant difference in Respiratory rate between the two groups.
FIGURE -10
RAMSAY SEDATION SCALE
                                                       
 
                                                      TABLE -11
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                                          VERBAL RATING SCALE
TIME IN 
HOURS VERBAL RATING SCALE
GROU
P P
GROU
P C
TOTA
L
CHI-SQUARE 
TEST
2
1.        COUNT
  %WITH IN  GROUP
18
90%
20
100%
38
95%
P-0.487
NOT SIG
2            COUNT
                    %WITH IN GROUP
2
10%
0
0%
2
5%
4
1.        COUNT
                    %WITH IN GROUP
0
0%
19
95%
19
47.5
P<0.001
SIG
1            COUNT
                     %WITH IN GROUP
16
80%
1
5%
17
42
2            COUNT
                     %WITH IN GROUP
4
100%
0
100%
4
100%
6
1.         COUNT
                     %WITH IN GROUP
6
30%
8
40%
14
35%
P-0.741
NOT SIG
2.         COUNT
                     %WITH IN GROUP
14
70%
12
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5FIGURE - 11
VERBAL RATING SCALE
    
 The  post-operative  pain  score(verbal  rating  scale)  was  found  to  be 
significantly low at 4, 12, 18 and 24 hours in Group C when compared to Group P. 
Significantly low pain scores were observed at 4, 12, 18 and 24 hours intervals in 
patients belonging to Group C( P < 0.001 at 4 ,12 and 24 hours intervals and P 
-0.004  at  18  hours  interval  )  than  Group  P  as  shown in  figure-11.  The  study 
demonstrated that pain relief was significantly better (P < 0.05) in patients who 
received  epidural  bupivacaine  with  clonidine  than  the  patients  who  received 
epidural bupivacaine with placebo. 
59
5                                                       TABLE -12
TIME OF FIRST RESCUE ANALGESIA
GROUP P VALUE
GROUP P GROUP C
MEAN ± SD MEAN ± SD
Time of first rescue 
analgesia(hrs)
3.27 ±0.53 6.05 ± 0.65 0.001
SIGNIFICANT
The mean time of first rescue analgesia (hours) was found to be (6.05±0.65 
hours) in Group C than the (3.27±0.53 hours) observed in Group P which was 
statistically significant (P-0.001)
FIGURE- 12
F
TABLE -13
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NO.OF POST OPERATIVE EPIDURAL TOP-UPS
The no of post  operative epidural top ups were significantly low (4 or 5 
doses) in group C compared to(6 or 7 doses) in group P.
FIGURE -13 - NO.OF POST OPERATIVE EPIDURAL TOP-UPS
F
DISCUSSION
Our knowledge of acute pain mechanisms has advanced sufficiently over the 
past decade so that rational rather than empirically derived therapy can be used by 
aiming specifically at interrupting the mechanisms responsible for the generation 
of clinical pain. Breakthrough pain after surgical procedures is now beginning to 
be recognized as constituting suboptimal management. This is an active research 
area. A number of clinical trials have been conducted to prove the efficacy of anti- 
nociceptive effect of α2 agonists using different techniques and different types of 
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drugs  with  conflicting  results.  The  use  of  epidural  techniques  also  offer  the 
advantage  of  effective prolonged postoperative analgesia  as  compared to  nerve 
blocks and local infiltrations.
           
The  dose-dependent  antinociceptive  effects  of  clonidine  were 
demonstrated in 1981 (1). These effects are partly mediated by spinal cord 
muscarinic and nicotinic receptors and the release of acetylcholine and by 
the activation of  inhibitory noradrenergic  pathways (10).  In  experimental 
studies,  animal  models  and  clinical  trials,  subarachnoid  opioids,  local 
anesthetics  and  α2 adrenergic  agonists  show  synergistic  or  additive 
interactions (10,11). Intrathecal or epidural  clonidine is not neurotoxic.
i
           In this study, we found that bupivacaine and clonidine administered 
epidurally,  reduced  the  amount  of  analgesic  that  patients  required 
postoperatively suggesting that clonidine may enhance the analgesic effect 
of  bupivacaine.  This  study  correlates  with  the  meta-analysis  done  by 
Armand et al (2) which concluded that epidural clonidine clearly produced 
an analgesic effect and reduced the need for other analgesics.                   
           In this randomized control study, we have evaluated the analgesic 
efficacy  of  bupivacaine  with  clonidine  mixture  given  through  lumbar 
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epidural  route  in  patient  undergoing  elective  orthopaedic  lower  limb 
surgeries.
           The level of sedation intraoperatively was monitored using Ramsay 
Sedation Scale. The patients in group C were well sedated and comfortable 
than in group P. This study correlates with the study conducted by Antonio 
Mauro et al(3) in which they concluded that the association of clonidine 
and  local  anaesthetic  (ropivacaine)  had  produced longer  analgesia  and 
sedation.
           Pain intensity was assessed using the verbal rating scale (VRS) 
post-operatively. Significant lower VRS scores after 2,4,6,8,12,18,24,26,48 
hours has in group C demonstrated the clinical advantage of administering 
mixture  of  bupivacaine  and  clonidine  through  lumbar  epidural  route  for 
effective postoperative analgesia. 
           Duration of analgesia was significantly more in group C patients  
receiving   bupivacaine   and  clonidine  mixture  (   6.05±0.64  hrs  )  as 
compared to group P (  3.26±0.53 hrs ). The demand for supplementary 
epidural  top-ups  over  48  hours  postoperatively  was  significantly  low  in 
group C than group P. This correlates with the study of Armand et al(2). 
           Two patients of placebo group (10% of group P) and two patients of 
clonidine  group  (10% of  group  C)  had  episodes  of  hypotension  with  a 
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MAP< 70 mm Hg during intraoperative period who were managed with a 
single dose of ephedrine 6 mg iv and crystalloids , and this may be as a 
result of epidural bupivacaine as such. In the studies conducted by Paech 
et  al  (17) and  Senard  et  al(21), they  have  concluded  that  epidural 
administration  of  clonidine  caused  a  dose  dependent  reduction  in 
haemodynamic parameters such as blood pressure and heart rate.
           Postoperatively none of the patients had episode of hypotension. No 
incidence  of  any  bradycardia  was  noted  in  both  the  group  during 
intraoperative and postoperative period.
SUMMARY
This  randomized  control  study  was  designed  to  evaluate  the  analgesic 
efficacy  of  bupivacaine  with  clonidine  mixture  given  through  lumbar  epidural 
route for postoperative analgesia in patients undergoing elective orthopaedic lower 
limb  surgeries  and  the  quality  of  analgesia  was  compared  with  epidural  plain 
bupivacaine.
Forty  ASA  I  &  II  patients  undergoing  elective  orthopaedic  lower  limb 
surgical procedure under epidural anaesthesia were randomly allocated into one of 
the two groups. Group P received 1 ml of normal saline along with first dose of 
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14ml 0.5% bupivacaine. Group C received 50 µg of clonidine diluted with normal 
saline to 1 ml along with the first dose of 14 ml 0.5% bupivacaine. Further top-up 
dose was given using 6 ml of 0.5 % bupivacaine, 90 min after the first dose. There 
was no complication encountered in technical skills in all forty patients.
Pain in the post-operative period was assessed using a verbal rating scale 
(VRS). Time of first rescue analgesic(TFA) and the supplementary analgesic doses 
required for 48 hours were noted for the two groups. Pain score were significantly 
less in Group C at 2,4,6,8,12,24,48 hours (P <0.05) than in group 
P. Overall pain score over 48 hours period also revealed better pain relief in 
group C (P<0.05) as compared to Group P.
Time of first rescue analgesic (TFA) in group C was significantly prolonged 
compared  with  group  P  .  The  postoperative  analgesic  consumption  was  also 
significantly less in group C than in group P. The incidence of hypotension did not 
differ significantly between the two groups & there was no bradycardia in both the 
groups.
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So  this  study  demonstrates  that  addition  of  clonidine  to  bupivacaine 
definitely  improves the quality of analgesia by reducing the overall  pain score, 
prolonging the duration of the time of first rescue analgesia and causing reduction 
of  total  analgesic  consumption  in  the  postoperative  period  without  any 
hemodynamic instability.
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CONCLUSION
1. Single  dose  administration  of  clonidine  and  bupivacaine   mixture 
given  through lumbar epidural route provides effective postoperative 
analgesia  in  patients   undergoing  elective  orthopaedic  lower  limb 
surgeries, without any hemodynamic instability. 
2. Epidural  clonidine significantly  reduces  the postoperative analgesic 
consumption.
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PROFORMA
Name          :                                   Height                     :
Age             :                Sex:            Weight                     :
I.P.No         :                                   Diagnosis                :
ASA Status :                                   Surgery                   :
Group        :                              Duration of surgery :
Time of injection of drugs:    Epidural I dose-
                                               Dose of Clonidine or Placebo-
 
                                               Epidural 2nd dose-
                                              
Time of incision-
INTRA
– OPERATIVE VITALS MONITORING
Time interval (minutes)
Sl.
No
Parameter Pre-op 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150
1. HR
2. SBP
3. DBP
4. MAP
5. RR
6. RSS
Intra–operative events:
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7POST–OPERATIVE   MONITORING
Parameter Time interval(hours)
2 hrs 4 hrs 6 hrs 8 hrs 12 hrs 18 hrs 24 hrs 48 hrs
1.Pain Score: 
(Verbal Rating 
Scale)
 0 – No Pain
 1 
– Mild Pain
 2 – Moderate Pain
 3 – Severe Pain
2.Adverse Effects: 
   Hypotension
   Bradycardia
POST–OPERATIVE ANALGESICS CONSUMPTION
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1. Time of First Rescue analgesic:  
(TFA in hours)
2. No.of  Supplementary epidural  top-  
ups required:
(for 48 hours)
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